Paulina D Kitcher, MD - Medicare Psychiatry & Neurology in Albany, NY

Paulina D Kitcher, MD is a medicare enrolled "Psychiatry & Neurology - Psychiatry" physician in Albany, New York. Her current practice location is 315 S Manning Blvd Ste 6408a, Albany, New York. You can reach out to her office (for appointments etc.) via phone at (518) 525-1303.

Paulina D Kitcher is licensed to practice in New York (license number 279888) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1710962089.

Contact Information

Paulina D Kitcher, MD
315 S Manning Blvd Ste 6408a,
Albany, NY 12208-1707
(518) 525-1303
Not Available



Physician's Profile

Full NamePaulina D Kitcher
GenderFemale
SpecialityPsychiatry & Neurology - Psychiatry
Location315 S Manning Blvd Ste 6408a, Albany, New York
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1710962089
  • Provider Enumeration Date: 12/09/2005
  • Last Update Date: 05/13/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 6709778335
  • Enrollment ID: I20131205000414

Medical Identifiers

Medical identifiers for Paulina D Kitcher such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1710962089NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2084P0800XPsychiatry & Neurology - Psychiatry 279888 (New York)Primary
2084P0800XPsychiatry & Neurology - Psychiatry 45256 (Wisconsin)Secondary
2084P0800XPsychiatry & Neurology - Psychiatry 51875 (Connecticut)Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Paulina D Kitcher allows following entities to bill medicare on her behalf.
Entity NameHartford Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1407806391
PECOS PAC ID: 2567366016
Enrollment ID: O20031125000700

News Archive

New portable device may hold key to faster diagnosis of schizophrenia

A portable device common in optometrists' offices may hold the key to faster diagnosis of schizophrenia, predicting relapse and symptom severity and assessing treatment effectiveness, a Rutgers University study finds.

First antiviral treatment for COVID-19 receives FDA approval

Today, the U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalization.

New type of regulatory T cell that reduces asthma and airway inflammation

The team's research not only provides a detailed profile of these newfound cells but also sheds light on how such cells are related to other T cells and suggests that there exists a spectrum of regulatory T cells, known as Tregs, to be identified and studied.

University of Utah geneticists engineer mice that develop clear cell sarcoma

Geneticists led by University of Utah Nobel Prize Laureate Mario R. Capecchi, Ph.D., have engineered mice that develop clear cell sarcoma (CCS), a significant step in better understanding how this rare and deadly soft tissue cancer arises. The mouse model also can potentially speed the development of drugs to target genes that must be activated for the cancer to form.

Bad experience with food could impact future eating habits

A negative experience with food usually leaves us unable to stomach the thought of eating that particular dish again.

Read more Medical News

› Verified 9 days ago

Entity NameHartford Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1770696643
PECOS PAC ID: 2567366016
Enrollment ID: O20031125000752

News Archive

New portable device may hold key to faster diagnosis of schizophrenia

A portable device common in optometrists' offices may hold the key to faster diagnosis of schizophrenia, predicting relapse and symptom severity and assessing treatment effectiveness, a Rutgers University study finds.

First antiviral treatment for COVID-19 receives FDA approval

Today, the U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalization.

New type of regulatory T cell that reduces asthma and airway inflammation

The team's research not only provides a detailed profile of these newfound cells but also sheds light on how such cells are related to other T cells and suggests that there exists a spectrum of regulatory T cells, known as Tregs, to be identified and studied.

University of Utah geneticists engineer mice that develop clear cell sarcoma

Geneticists led by University of Utah Nobel Prize Laureate Mario R. Capecchi, Ph.D., have engineered mice that develop clear cell sarcoma (CCS), a significant step in better understanding how this rare and deadly soft tissue cancer arises. The mouse model also can potentially speed the development of drugs to target genes that must be activated for the cancer to form.

Bad experience with food could impact future eating habits

A negative experience with food usually leaves us unable to stomach the thought of eating that particular dish again.

Read more Medical News

› Verified 9 days ago

Entity NameNatchaug Hospital, Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1295811321
PECOS PAC ID: 5395648737
Enrollment ID: O20040202000008

News Archive

New portable device may hold key to faster diagnosis of schizophrenia

A portable device common in optometrists' offices may hold the key to faster diagnosis of schizophrenia, predicting relapse and symptom severity and assessing treatment effectiveness, a Rutgers University study finds.

First antiviral treatment for COVID-19 receives FDA approval

Today, the U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalization.

New type of regulatory T cell that reduces asthma and airway inflammation

The team's research not only provides a detailed profile of these newfound cells but also sheds light on how such cells are related to other T cells and suggests that there exists a spectrum of regulatory T cells, known as Tregs, to be identified and studied.

University of Utah geneticists engineer mice that develop clear cell sarcoma

Geneticists led by University of Utah Nobel Prize Laureate Mario R. Capecchi, Ph.D., have engineered mice that develop clear cell sarcoma (CCS), a significant step in better understanding how this rare and deadly soft tissue cancer arises. The mouse model also can potentially speed the development of drugs to target genes that must be activated for the cancer to form.

Bad experience with food could impact future eating habits

A negative experience with food usually leaves us unable to stomach the thought of eating that particular dish again.

Read more Medical News

› Verified 9 days ago

Entity NameThe William W Backus Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1467517235
PECOS PAC ID: 0749170645
Enrollment ID: O20040316000739

News Archive

New portable device may hold key to faster diagnosis of schizophrenia

A portable device common in optometrists' offices may hold the key to faster diagnosis of schizophrenia, predicting relapse and symptom severity and assessing treatment effectiveness, a Rutgers University study finds.

First antiviral treatment for COVID-19 receives FDA approval

Today, the U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalization.

New type of regulatory T cell that reduces asthma and airway inflammation

The team's research not only provides a detailed profile of these newfound cells but also sheds light on how such cells are related to other T cells and suggests that there exists a spectrum of regulatory T cells, known as Tregs, to be identified and studied.

University of Utah geneticists engineer mice that develop clear cell sarcoma

Geneticists led by University of Utah Nobel Prize Laureate Mario R. Capecchi, Ph.D., have engineered mice that develop clear cell sarcoma (CCS), a significant step in better understanding how this rare and deadly soft tissue cancer arises. The mouse model also can potentially speed the development of drugs to target genes that must be activated for the cancer to form.

Bad experience with food could impact future eating habits

A negative experience with food usually leaves us unable to stomach the thought of eating that particular dish again.

Read more Medical News

› Verified 9 days ago

Entity NameSt. Vincent's Multispecialty Group Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1043544489
PECOS PAC ID: 6204977218
Enrollment ID: O20100112000538

News Archive

New portable device may hold key to faster diagnosis of schizophrenia

A portable device common in optometrists' offices may hold the key to faster diagnosis of schizophrenia, predicting relapse and symptom severity and assessing treatment effectiveness, a Rutgers University study finds.

First antiviral treatment for COVID-19 receives FDA approval

Today, the U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalization.

New type of regulatory T cell that reduces asthma and airway inflammation

The team's research not only provides a detailed profile of these newfound cells but also sheds light on how such cells are related to other T cells and suggests that there exists a spectrum of regulatory T cells, known as Tregs, to be identified and studied.

University of Utah geneticists engineer mice that develop clear cell sarcoma

Geneticists led by University of Utah Nobel Prize Laureate Mario R. Capecchi, Ph.D., have engineered mice that develop clear cell sarcoma (CCS), a significant step in better understanding how this rare and deadly soft tissue cancer arises. The mouse model also can potentially speed the development of drugs to target genes that must be activated for the cancer to form.

Bad experience with food could impact future eating habits

A negative experience with food usually leaves us unable to stomach the thought of eating that particular dish again.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Paulina D Kitcher is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Paulina D Kitcher, MD
428 N Superior St Ste 110,
De Pere, WI 54115

Ph: (707) 376-8636
Paulina D Kitcher, MD
315 S Manning Blvd Ste 6408a,
Albany, NY 12208-1707

Ph: (518) 525-1303

News Archive

New portable device may hold key to faster diagnosis of schizophrenia

A portable device common in optometrists' offices may hold the key to faster diagnosis of schizophrenia, predicting relapse and symptom severity and assessing treatment effectiveness, a Rutgers University study finds.

First antiviral treatment for COVID-19 receives FDA approval

Today, the U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalization.

New type of regulatory T cell that reduces asthma and airway inflammation

The team's research not only provides a detailed profile of these newfound cells but also sheds light on how such cells are related to other T cells and suggests that there exists a spectrum of regulatory T cells, known as Tregs, to be identified and studied.

University of Utah geneticists engineer mice that develop clear cell sarcoma

Geneticists led by University of Utah Nobel Prize Laureate Mario R. Capecchi, Ph.D., have engineered mice that develop clear cell sarcoma (CCS), a significant step in better understanding how this rare and deadly soft tissue cancer arises. The mouse model also can potentially speed the development of drugs to target genes that must be activated for the cancer to form.

Bad experience with food could impact future eating habits

A negative experience with food usually leaves us unable to stomach the thought of eating that particular dish again.

Read more News

› Verified 9 days ago


Psychiatry & Neurology Doctors in Albany, NY

Dr. Stanley F Penc, MD PHD
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 400 Patroon Creek Blvd, Suite 210, Albany, NY 12206
Phone: 518-459-8106    
Dr. Donald Stone Higgins Jr., M.D.
Psychiatry & Neurology
Medicare: Not Enrolled in Medicare
Practice Location: 113 Holland Ave, Neurology Service (127), Albany, NY 12208
Phone: 518-626-6391    Fax: 518-626-6369
Dr. Christopher John Hanowitz, M.D.
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 47 New Scotland Ave, Department Of Emergency Medicine, Albany, NY 12208
Phone: 518-262-3095    
Daniel Gabriels,
Psychiatry & Neurology
Medicare: Not Enrolled in Medicare
Practice Location: 75 New Scotland Ave, Albany, NY 12208
Phone: 518-447-9611    
Ryan Patrick Bochacki, MD
Psychiatry & Neurology
Medicare: Not Enrolled in Medicare
Practice Location: 113 Holland Ave, Albany, NY 12208
Phone: 518-626-5991    
Dr. Amanda Jane Crosier-riffle, MD
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 315 S Manning Blvd, Albany, NY 12208
Phone: 518-525-1303    
Robert F. Malerba Ii, MD
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 732 Madison Ave, Albany, NY 12208
Phone: 518-436-0874    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.